Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer

INTRODUCTION: Non-small cell lung cancer (NSCLC) is the leading cause of cancer incidence and mortality worldwide. Neoadjuvant chemo-immunotherapy has led to clinical benefits in resectable NSCLC in comparison to chemo-therapy alone. Major pathological response (MPR) and pathological complete respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Alì, Greta, Poma, Anello Marcello, Di Stefano, Iosè, Zirafa, Carmelina Cristina, Lenzini, Alessandra, Martinelli, Giulia, Romano, Gaetano, Chella, Antonio, Baldini, Editta, Melfi, Franca, Fontanini, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947557/
https://www.ncbi.nlm.nih.gov/pubmed/36845706
http://dx.doi.org/10.3389/fonc.2023.1115156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947557/
https://www.ncbi.nlm.nih.gov/pubmed/36845706
http://dx.doi.org/10.3389/fonc.2023.1115156

Ejemplares similares